J O Moore
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Erythropoietin and Anemia Treatment 1
- Genetics 2
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- E A HardenGregg A. OlsenMichael S. HershfieldJoanne KurtzbergB F HaynesBF HaynesMS HershfieldWaldmann Ta
- Journals
- Journal of Clinical Oncology (1 paper)Proceedings of the National Academy of Sciences (1 paper)Blood (1 paper)Surrey Research Insight Open Access (The University of Surrey) (1 paper)PubMed (5 papers)
- Partner nations
- United States
In The Last Decade
J O Moore
9 papers receiving 570 citations
Peers
Comparison fields: 5 of 67
- Hematology 436
- Genetics 126
- Public Health, Environmental and Occupational Health 169
- Immunology 113
- Oncology 102
Countries citing papers authored by J O Moore
This map shows the geographic impact of J O Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J O Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J O Moore more than expected).
Fields of papers citing papers by J O Moore
This network shows the impact of papers produced by J O Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J O Moore. The network helps show where J O Moore may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J O Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 13 | |
| 2 | Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. | 2006 | 36 |
| 3 | 2004 | 10 | |
| 4 | 1997 | 180 | |
| 5 | 1989 | 126 | |
| 6 | Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells. | 1988 | 11 |
| 7 | Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. | 1987 | 61 |
| 8 | 1984 | 130 | |
| 9 | Mitoxantrone in the treatment of relapsed and refractory acute leukemia. | 1984 | 33 |
About J O Moore
J O Moore is a scholar working on Hematology, Genetics, Nephrology, Reproductive Medicine and Dermatology, having authored 9 papers that have together received 600 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Healthcare Policy and Management (1 paper), Erythropoietin and Anemia Treatment (1 paper), Neutropenia and Cancer Infections (1 paper), Myasthenia Gravis and Thymoma (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Hematology (436 citations), Genetics (126 citations), Public Health, Environmental and Occupational Health (169 citations), Immunology (113 citations) and Oncology (102 citations). J O Moore has collaborated with scholars based in United States. Frequent co-authors include E A Harden, Gregg A. Olsen, Michael S. Hershfield, Joanne Kurtzberg, B F Haynes, Joanne Kurtzberg, BF Haynes, MS Hershfield, Waldmann Ta and C. D. Bloomfield. Their work appears in journals such as Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Blood, Surrey Research Insight Open Access (The University of Surrey) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.